The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib evaluation of MPDL3280A (anti-PDL1) in combination with bevacizumab (bev) in patients (pts) with metastatic renal cell carcinoma (mRCC).
 
Mario Sznol
Consulting or Advisory Role - Amgen; Anaeropharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Immune Design; Kyowa Hakko Kirin; Lion Biotechnologies; Merus; Nektar; Symphony Evolution
Other Relationship - Haymarket Media
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Suzanne Fields Jones
No Relationships to Disclose
 
James Walter Mier
Patents, Royalties, Other Intellectual Property - Acceleron Pharma
 
Daniel Waterkamp
Employment - Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
 
Cheryl Rossi
Employment - PRO Unlimited
Leadership - BioRx
Stock and Other Ownership Interests - Gilead Sciences; Merck; Novo Nordisk
Travel, Accommodations, Expenses - Genentech
 
Jeffrey Wallin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Patents, Royalties, Other Intellectual Property - Genentech
Travel, Accommodations, Expenses - Genentech
 
Roel Peter Funke
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Johanna C. Bendell
No Relationships to Disclose